Although nevirapine (NVP) is provided by prevention of mother-to-child-transmission (PMTCT) of HIV programmes to be taken at onset of labor independent of place of delivery, few studies have assessed adherence to NVP outside the hospital setting. This study aimed to follow women in a PMTCT programme up to delivery and to assess the adherence to the prophylaxis in rural Malawi. A total of 75 HIV-positive women were registered in the PMTCT at Malamulo SDA hospital between January and June 2005. Forty women (53%) delivered in the hospital and 35 (47%) did not. Of the 35 women who delivered at home, it was possible to trace 27 (77.2%). All women who delivered in the hospital took their NVP tablets and all their babies had NVP syrup except one baby who died soon after delivery. Of the 27 traced women who had not delivered in the hospital, 16 (59.3%) had access to NVP and had taken their tablets during labor. However, none of their babies was taken back to the health facility for NVP syrup. Traditional birth attendants might be crucial in efforts aiming to increase adherence to NVP among women and their babies.
Introduction
In 2005, 750,000 children under 15 became infected with HIV, mainly through mother to child transmission (MTCT). About 90% of these MTCT infections occurred in Africa where AIDS is beginning to reverse decades of steady progress in child survival. Without specific interventions, the rate of MTCT is approximately 15 Á20%, with prolonged breastfeeding doubling the rate to 35 Á40%. In high-income countries, MTCT rates of less than 2% are reported, thanks to effective voluntary counseling and testing (VCT), access to antiretroviral (ARV) therapy, safe delivery practices and the widespread availability and safe use of breastmilk substitutes (Newell, 2006) .
Malawi has one of the highest HIV/AIDS prevalence rates in the world, with an average of 14% of adults between 15 Á49 years infected (MOHP, 2003a) . Among the pregnant women attending antenatal clinic in Malawi, HIV prevalence ranges from 16 Á36%. In 2003, 520,000 women of childbearing age were estimated to be infected with HIV in Malawi (MOHP, 2003b) .
The prevention of mother-to-child transmission is a cornerstone in the scale-up of HIV programmes. Studies have shown that a single dose of nevirapine (NVP) given to the mother at the onset of labour and to the baby within 72 hours after delivery will reduce the rate of HIV transmission by almost half (Guay et al., 1999 , Nolan el al., 2002 . As it is given only once to the mother and baby, single dose NVP is relatively cheap and easy to administer. Children in resource-poor countries have benefited from this intervention, which has been the mainstay of many PMTCT programmes (Manzi et al., 2005; Welty et al., 2005) . However, PMTCT is more than a prophylaxis with a proven potential to significantly reduce the overall incidence of HIV transmission, it also informs women and their partners on their status and helps them accessing treatment and support services.
Malawi's goal is to establish universal access to PMTCT. By the end of the decade 90% of pregnant women and their partners visiting antenatal clinics (ANC) should have the opportunity to be tested for HIV in PMTCT service delivery points and access ARV prophylaxis (MOHP, 2003a) .
However, even when PMTCT programmes are available, women face multiple challenges in adhering to PMTCT services and the ARV prophylaxis, particularly those in rural areas (Bajunirwe & Muzoora, 2005) . Several studies have reported a severe loss to follow-up from registration up to delivery in PMTCT programmes (Manzi et al., 2005; Perez et al., 2004; Stringer et al., 2005; Temmerman et al., 2003) . Although NVP is provided by the PMTCT programme to be taken at onset of labour independent of place of delivery, few studies so far have assessed adherence to NVP outside the hospital setting. In one study from Lusaka in Zambia non adherence was strongly associated with home deliveries (Albrecth et al., 2006) . This study aims to follow the women in a PMTCT programme up to delivery regardless of place and assess how the women and their babies adhere to the prophylaxis in rural Malawi.
Methods

Study area
The Government and non-governmental organizations (NGOs) deliver healthcare services in Malawi. Health facilities ran by faith-based institutions have membership of an organization called Christian Health Association of Malawi. Malamulo mission hospital, where this study was peformed, is a member of this organization, is owned by the Seventh Day Adventist Church and is located in the southern region of Malawi, in Thyolo District. It was established in 1902 and remains the headquarters of the Adventist Church in Malawi. The hospital has 15 mobile sites with two health centres and collaborates with other NGOs in the district as well as with Thyolo District Hospital.
Malamulo functions as a teaching hospital in the country for allied health workers namely nurses, medical auxiliaries and laboratory technicians and has 300 beds. It serves an estimated population of over 70,000 and focuses on both curative and preventive services. Fertility rate in this area is somewhat higher than the national rate of 6.2 children per woman (National Statistics Office, 2000) . Up to 46% of pregnant mothers in this area deliver outside the hospital for various reasons (MOHP, 2000) .
Communication is a problem due to poor roads and this is worse during rainy season. Socioeconomic status in this area is low. Many people are seasonal migrant workers in the tea and coffee estates that surround Malamulo hospital. Most are peasant farmers. They grow maize, beans, cassava and bananas among other crops, mainly for home consumption. Crops are usually poor since most modern farming methods are not widely used. Malnutrition and communicable diseases, such as malaria, worm infestation, tuberculosis, diarrhoeal diseases and sexually transmitted infections (STIs) including HIV/AIDS are common.
The HIV prevalence rate in this population is estimated at 16%, slightly higher than the national rate of 14% (MOHP, 2003a). Many families have experienced a loss of a member due to AIDS, therefore, the number of orphans is also high. To compliment the Malawi Government's efforts through its Ministry of Health, Malamulo carries out an Integrated HIV/AIDS Prevention Project. The project began in 1988 as Child Spacing with funding from local and international donors. Over the years a number of activities have been added to the project, which today offers comprehensive community based services. The project components are VCT, management of STIs, home based care (HBC), youth friendly health services, family planning, PMTCT of HIV, ARV provision, nutrition, static and outreach mother and child health services. Currently the project is funded mainly by Save the Children US through a local NGO called Umoyo Network.
PMTCT at Malamulo SDA hospital
Prevention of mother-to-child-transmission at Malamulo hospital was introduced in July 2004 as a PMTCT Plus programme because it supports the provision of specialised care to HIV-infected women, namely ARV treatment, STIs, HBC, infant feeding practices and nutrition. It further adopts national and international standards according to the World Health Organization (WHO, 2004) .
The antenatal clinic registers all pregnant mothers who come for the services. In additional to general ANC services, health education on HIV/AIDS and the importance of HIV testing are given to all the mothers.
Those who opt to take the HIV test undergo preand post-test counselling sessions and, if found HIV-positive, are included in the PMTCT programme. They are further given information regarding NVP and the importance of delivering at the hospital. Nevirapine 200mg tablets are given to the mothers at 32 Á38 weeks to take when labour starts. It is not possible to provide the mother with the NVP syrup for the baby due to difficulties of storage and a short shelf life. At the hospital NVP syrup 2mg/kg is given to the baby within 72 hours of delivery. If a mother is unable to get to the hospital for delivery she is expected to return within 72 hours of delivery to ensure administration of NVP to the newborn child.
Ideally mothers and their babies are followed-up for 18 months. The first six months are intensive as mothers are taught about infant feeding practices, optional feeding, transitional feeding and exclusive breastfeeding for at least 4 Á6 months. At six months the child stops breastfeeding and is given Bactrim 240 mg daily until 18 months as a prophylaxis. At 18 months the child's HIV status is determined.
Data collection and analysis
A total of 719 mothers were registered in the Malamulo Hospital antenatal clinic from January to June 2005. Six-hundred and eighty six (95.4%) antenatal mothers accepted pre-test counselling and 604 (84.0%) finally accepted HIV testing. Seventyfive (12.4%) women tested HIV-positive and were included in the PMTCT programme ( Figure 1 ). These women were followed-up from antenatal clinic to delivery by use of routine antenatal, PMTCT and PMTCT delivery registers. Women who did not return for delivery in the hospital were traced and interviewed in their homes. Data on place of delivery, support, reasons for non-hospital delivery and outcome of delivery were collected from the traced mothers who had not delivered at the hospital. Interviews were conducted by the programme manager. Care was taken not to blame any women for decisions taken but to support further contact with health services.
Data analysis was done using the Epi Info software (version 6.04d, Centers for Disease Control and Prevention, Atlanta GA, US). T-test for means and Chi-square for proportions were used when comparing characteristics between (1) infected women who picked up NVP in week 32' and those who did not and (2) infected women who delivered in the hospital and those who did not.
Ethical considerations
Consent was obtained from Malamulo Hospital Administrative Council. Chiefs and respondents gave their oral informed consent as well. All the respondents were assured that information given would be treated with strict confidentiality. 
Results
Characteristics of the study population
A total of 75 mothers (mean age 25.5 years) were registered in the PMTCT of Malamulo SDA hospital between January and June 2005. Of these, 74 (98.7%) were married and the rest (1.3%) single. Sixty-seven women (89.3%) were housewives and the rest (10.7%) had some form of employment. Ten women (13.3%) were illiterate and 32 (42.7%) had not completed primary school. Twenty-nine women (38.7%) traveled less than 5 km to the hospital and nearly half (37; 49.3%) traveled 5 Á10 km while the remaining (12%) had to travel more than 10 km. Over half of the women (38; 50.7%) were going to give birth to their first or second child while only seven women (9.3%) had already given birth to three or more children. More than two-thirds of the women (51; 68.0%) registered in the ANC program in their second trimester. Sixteen women (21.3%) came to the ANC clinic only once and 28 women (37.3%) had three of more check ups during their pregnancy. All women were tested for syphilis and four (5.3%) were VDRL positive (see Table I ).
Provision of antiretroviral prophylaxis to HIV-infected women
Of 75 HIV-positive women, 60 (80%) came for check ups during gestation week 32 Á38. These women were then provided with NVP to be taken at the time of labour. There were no sociodemographic differences noted between the women who did receive nevirapine and those who did not (data not shown).
Place of delivery among HIV-infected women and delivery outcomes
Forty women (53%) delivered in the hospital and 35 (47%) did not (see Figure 1 ). Although the proportion of women living less than 5 km from the hospital was higher in the group who delivered in the hospital (47.5 versus 28.6%) the difference was not significant. No other socioeconomic differences were observed (see Table II ). However, women who delivered in the hospital were only found among the group who had returned to the antenatal clinic after week-32 when NVP was handed out. Among the women who did not deliver in the hospital, 20 (57%) picked up the NVP before delivery. Of the 35 women who delivered at home, it was possible to trace 27 (77.2%). Twenty-six of the women (96.3%) who were traced had delivered in the home of a traditional birth attendant and one woman (3.7%) on the way to the hospital. Twentyone (77.7%) women who did not deliver at the The 40 women who delivered in the hospital all had normal deliveries. Hospital delivery outcomes were 40 live births and one stillbirth. One baby died soon after delivery. The 27 women who were traced among the group who did not deliver in the hospital had in total 27 babies. Three (11.1%) of them died soon after delivery and four (14.8%) were reported by their mothers to be underweight.
All women who delivered in the hospital had taken their NVP tablets and all the babies had had their NVP syrup except the baby who died soon after delivery. Of the 27 traced women who had not delivered in the hospital, 16 (59.3%) had picked up NVP from the PMTCT clinic and all of these women had also taken their tablets during labour. However, none of their babies were taken back to the health facility to be given NVP syrup (Figure 1 ).
Discussion
The study showed that in this rural setting more than 12% of the pregnant mothers presenting themselves to the clinic were HIV-infected. The willingness to be tested was relatively high, 84% of all and 88% of those pre-test counselled. This might increase if an 'opt-out' policy was implemented, as has been experienced in other centers in rural Malawi (Manzi et al., 2005) . Slightly above half (53%) of HIV-infected mothers delivered in the hospital. This is very similar to the overall proportion of approximately 50% of all women (regardless of HIV status) registering at the antenatal clinic who later delivered at the hospital during the study period. It is worrisome that 47% of HIV-infected mothers delivered at home regardless of the given instructions to deliver at the hospital. Although some of these mothers got antiretroviral prophylaxis from the antenatal clinic and took it when labor began, their babies did not return to the health facility within 72 hours, the acceptable time for administering the NVP syrup to the baby.
It is important to remember, however, that the majority of children are delivered outside a hospital setting in sub-Saharan Africa (WHO, 2006) and, in general, Malawi has a low rate of institutional deliveries (McCoy et al., 2004) . Rural women are faced with multiple challenges that prevent them from accessing healthcare services. Low socioeconomic status and gender-related imbalances have been cited by many studies as factors affecting rural women's utilisation of health services (Ebeigbe et al., 2005; Lindgren et al., 2005) . This is common in many parts of southern Africa, where infant and maternal mortality rates are exceptionally high.
In addition, women might have experienced difficulties related to their HIV status that prevented them from delivering at the hospital in the first place or returning to the health facility for NVP syrup to their baby. Issues of fear of disclosure, lack of family support, stigma, rejection and discrimination could be some of the problems faced by these women upon returning home with HIV-positive test results (Maman et al., 2003; Medley et al., 2004) .
In our study women reported that distance, lack of money to pay for delivery expenses and sickness were the main reasons for women not accessing hospital delivery services. These are reasons that are not related directly to their HIV status. However there is need to further study barriers and promoting factors to delivery of antiretroviral prophylaxis to mothers attending PMTCT services to reach a deeper understanding.
It was further found that all the HIV-infected mothers who had received NVP during their antenatal visits and later delivered at home, took their antiretroviral prophylaxis. Although this is based on the women's own report we think it reflects the reality in this particular setting. It is also interesting to note that all the women who later came to deliver at the hospital also had received NVP during their antenatal visits. This implies that the women who do not come back to the antenatal clinic after week-32 when NVP is handed out are not likely to be seen later in the hospital for delivery and consist of a vulnerable group. They constitute a vulnerable group that should be given special attention.
Only distance of less than five km to hospital was associated with hospital delivery. There were no significant differences of sociodemographic characteristics in the groups that were compared between women who had picked up NVP and those who had not, or those women who delivered at the hospital and those who did not. This could be explained by the fact that the sample of HIV-infected women in the study was small but also by it being a rather homogenous population. Financial constraints and failure to capture data from some of the infected mothers with home deliveries due to migration were also limitations in the study. However, the study has the strength of assessing the adherence to NVP in a routine PMTCT programme.
Adherence to antiretroviral prophylaxis is as well an enormous challenge among the marginalized HIV-infected women. These challenges cannot be separated from those faced by the high maternal mortality in Malawi (McCoy et al., 2004 ). An overall strengthening of antenatal and delivery services in rural areas of the country is urgent. In addition, education at the antenatal care clinic should be intensified to all the antenatal mothers with emphasis on those put on antiretroviral prophylaxis. A further plan to decentralise PMTCT and antiretroviral prophylaxis delivery points should also be considered. Traditional birth attendants assisted the women who did not deliver in the hospital. They might be crucial in efforts aiming to increase the adherence among women and their babies to NVP. It will be important however to study the perceptions the women have of the confidentiality of traditional birth attendants before giving them a role in the PMTCT programme. the study. Fyson Kasenga received financial support from the Swedish Institute, Sweden and is also grateful for the support given by the unit of Epidemiology and Public Health Sciences, Umeå University.
